Two medical centers in Vermont kick off a new pilot program on May 1 that circumvents the onerous pre-authorization process by preapproving selected lumbar spine MRIs.

A new study from Karolinska Institute in Stockholm, Sweden, demonstrated that a noninvasive screening protocol of MRI alone in individuals at high risk of pancreatic cancer resulted in a lesion yield of 40% in the screened patients.

The Food and Drug Administration has issued two separate Class 2 recalls involving Siemens and GE MRI systems.

At a time when 85% of physicians are viewing diagnostic images via electronic medical records, the opportunity is ripe to realize true enterprise imaging. More of those docs should be saying goodbye to walled-off image silos and hello to a centralized, always-open image depot. 

A new magnetic resonance imaging technique could potentially make biopsies obsolete by noninvasively detecting sugar molecules that are shed by the outer membranes of cancerous cells.

The medical imaging community is buzzing over the GE MRI recall—by now, no other words are needed to name it—and the chatter will probably continue for a long time to come.

GE is recalling almost 13,000 MRI units, as the FDA has deemed them potentially deadly.

Citing issues with how the magnetic rundown unit (MRU) is connected to the magnet at some MRI sites, the Food and Drug Administration (FDA) has issued a Class 1 recall for all GE Healthcare MRIs with superconducting magnets, and GE Healthcare is asking its customers to perform a test to ensure that the MRU is properly connected.